Mark de Belder

14.0k total citations · 1 hit paper
241 papers, 6.4k citations indexed

About

Mark de Belder is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark de Belder has authored 241 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Cardiology and Cardiovascular Medicine, 90 papers in Surgery and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark de Belder's work include Acute Myocardial Infarction Research (107 papers), Coronary Interventions and Diagnostics (68 papers) and Cardiac Imaging and Diagnostics (48 papers). Mark de Belder is often cited by papers focused on Acute Myocardial Infarction Research (107 papers), Coronary Interventions and Diagnostics (68 papers) and Cardiac Imaging and Diagnostics (48 papers). Mark de Belder collaborates with scholars based in United Kingdom, United States and Canada. Mark de Belder's co-authors include Mamas A. Mamas, Peter Ludman, Chun Shing Kwok, Chris P Gale, A. John Camm, John Deanfield, James Nolan, Tim Kinnaird, James Hall and Evangelos Kontopantelis and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark de Belder

231 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

2020 430 citations Marion Mafham, Chris Roebuck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark de Belder United Kingdom	44	4.3k	2.1k	1.6k	1.2k	1.0k	241	6.4k
Kevin F. Kennedy United States	45	3.9k 0.9×	2.9k 1.4×	1.8k 1.1×	1.5k 1.3×	1.3k 1.2×	345	7.9k
Herbert D. Aronow United States	35	2.4k 0.6×	1.8k 0.8×	1.8k 1.1×	349 0.3×	1.0k 1.0×	229	4.7k
Richard E. Shaw United States	49	4.5k 1.1×	4.2k 1.9×	1.3k 0.8×	2.1k 1.7×	425 0.4×	180	7.3k
Karl E. Hammermeister United States	43	6.3k 1.5×	4.3k 2.0×	1.6k 1.0×	1.1k 1.0×	1.4k 1.4×	132	9.5k
Gerald T. O’Connor United States	50	3.7k 0.9×	3.3k 1.6×	1.7k 1.0×	612 0.5×	937 0.9×	112	7.3k
Mauricio G. Cohen United States	40	3.8k 0.9×	2.8k 1.3×	1.7k 1.1×	771 0.6×	953 0.9×	256	6.9k
Harindra C. Wijeysundera Canada	39	4.2k 1.0×	1.8k 0.9×	936 0.6×	1.1k 0.9×	1.4k 1.4×	326	6.0k
Samer A.M. Nashef United Kingdom	27	5.4k 1.3×	3.5k 1.6×	1.8k 1.1×	731 0.6×	1.5k 1.5×	113	7.5k
J. Sanford Schwartz United States	25	1.8k 0.4×	1.3k 0.6×	743 0.5×	593 0.5×	391 0.4×	47	4.2k
Frederick A. Spencer United States	48	7.4k 1.7×	2.9k 1.4×	552 0.3×	2.0k 1.7×	791 0.8×	156	10.4k

Countries citing papers authored by Mark de Belder

Since Specialization

Citations

This map shows the geographic impact of Mark de Belder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark de Belder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark de Belder more than expected).

Fields of papers citing papers by Mark de Belder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark de Belder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark de Belder. The network helps show where Mark de Belder may publish in the future.

Co-authorship network of co-authors of Mark de Belder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark de Belder. A scholar is included among the top collaborators of Mark de Belder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark de Belder. Mark de Belder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Peter D., et al.. (2026). Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and Wales. Heart. heartjnl–2025.

Cannatà, Antonio, Mehrdad A. Mizani, Daniel I. Bromage, et al.. (2024). Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure. JACC Heart Failure. 13(3). 402–413. 6 indexed citations

Welch, Christine A., Nicolò Matteo Luca Battisti, Michael Sweeting, et al.. (2023). Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analysis. Clinical Oncology. 35(12). e708–e719. 3 indexed citations

Belder, Mark de, et al.. (2022). Cardiac audit, data and registries: evolution of a national programme. Heart. 108(10). 807–812. 3 indexed citations

Wu, Jianhua, Marion Mafham, Mamas A. Mamas, et al.. (2021). Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective Cohort Study of 3.5 Million Deaths in England and Wales, 2014 to 2020. Mayo Clinic Proceedings. 96(4). 952–963. 41 indexed citations

Shoaib, Ahmad, Harriette G.C. Van Spall, Jianhua Wu, et al.. (2021). Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal - Quality of Care and Clinical Outcomes. 7(4). 378–387. 43 indexed citations

Rashid, Muhammad, Jianhua Wu, Adam Timmis, et al.. (2021). Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. Journal of Internal Medicine. 290(1). 88–100. 39 indexed citations

Aktaa, Suleman, Mohammad E Yadegarfar, Jianhua Wu, et al.. (2021). Quality of acute myocardial infarction care in England and Wales during the COVID-19 pandemic: linked nationwide cohort study. BMJ Quality & Safety. 31(2). 116–122. 8 indexed citations

Martin, Glen P., Nick Curzen, Andrew Goodwin, et al.. (2021). Indirect Impact of the COVID-19 Pandemic on Activity and Outcomes of Transcatheter and Surgical Treatment of Aortic Stenosis in England. Circulation Cardiovascular Interventions. 14(5). e010413–e010413. 16 indexed citations

10.

Mohamed, Mohamed O., Amitava Banerjee, Sarah Clarke, et al.. (2020). Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality. European Heart Journal - Quality of Care and Clinical Outcomes. 7(3). 247–256. 49 indexed citations

11.

Rashid, Muhammad, Chris P Gale, Nick Curzen, et al.. (2020). Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out‐of‐Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England. Journal of the American Heart Association. 9(22). e018379–e018379. 59 indexed citations

12.

Holroyd, Eric, Alex Sirker, Chun Shing Kwok, et al.. (2017). The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes. JACC: Cardiovascular Interventions. 10(13). 1283–1292. 81 indexed citations

13.

McAllister, Katherine, Peter Ludman, William Hulme, et al.. (2016). A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales. International Journal of Cardiology. 210. 125–132. 51 indexed citations

14.

Kwok, Chun Shing, Muhammad Arif Khan, Sunil V. Rao, et al.. (2015). Access and Non–Access Site Bleeding After Percutaneous Coronary Intervention and Risk of Subsequent Mortality and Major Adverse Cardiovascular Events. Circulation Cardiovascular Interventions. 8(4). 80 indexed citations

15.

Ludman, Peter, Neil Moat, Mark de Belder, et al.. (2015). Transcatheter Aortic Valve Implantation in the United Kingdom. Circulation. 131(13). 1181–1190. 214 indexed citations

16.

Eldabe, Sam, Simon Thomson, Andrea Manca, et al.. (2013). The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): study protocol for a pilot randomized controlled trial. Trials. 14(1). 57–57. 9 indexed citations

17.

McLenachan, James M., Huon Gray, Mark de Belder, et al.. (2012). Developing primary PCI as a national reperfusion strategy for patients with ST-elevation myocardial infarction: the UK experience. EuroIntervention. 8(P). P99–P107. 13 indexed citations

18.

Hancock, Helen, Helen Close, James Mason, et al.. (2012). High Prevalence of Undetected Heart Failure in Long-Term Care Residents: Findings from the Heart Failure in Care Homes (HFinCH) Study. European Journal of Heart Failure. 15(2). 158–165. 55 indexed citations

19.

Turley, Andrew, Anthony Roberts, Robert Morley, et al.. (2007). Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. Interactive Cardiovascular and Thoracic Surgery. 7(2). 231–234. 17 indexed citations

20.

Gill, Jaswinder, Mark de Belder, & David Ward. (1994). Right ventricular outflow tract ventricular tachycardia associated with an aneurysmal malformation: Use of transesophageal echocardiography during low-energy, direct-current ablation. American Heart Journal. 128(3). 620–623. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact